Skip to main content
Figure 3 | BMC Medical Genomics

Figure 3

From: Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients

Figure 3

miR-21-5p expression in all samples included in the study. Patients were divided in 3 groups according to nCRT response: patients with initial cCR followed by early local recurrence (n = 4), incomplete responders (n = 25), and complete responders (n = 14). miR-21-5p expression is given as normalized values (cpm) from RNA-Seq data. Statistical analysis was performed with EdgeR (*FDR < 0.05).

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us